Literature DB >> 1728954

Amplification of ETS2 oncogene in acute nonlymphoblastic leukemia with t(6;21;18).

A Santoro1, A Maggio, P Carbone, S Mirto, F Caronia, S Acuto.   

Abstract

Cytogenetic and molecular studies in a case of acute nonlymphoblastic leukemia (ANLL) are reported in this paper. Bone marrow blasts carried a hypodiploid karyotype with a complex t(6;18;21)(6qter----6p21::21q22----21qter;18qter ----18p11::6p22----6pter; 21pter----21q22::6p21----6p22::18p11----18pte r) and other numerical and structural changes. We studied the organization and the expression of the ETS2 gene which is located on chromosome 21 in order to investigate its possible involvement in the disease. DNA analysis showed a 20-fold amplification of ETS2 sequences; an increase of 3- to 4-fold in the mRNAs level compared to normal was shown by Northern hybridization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728954     DOI: 10.1016/0165-4608(92)90137-w

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Overexpression of ETS2 in human esophageal squamous cell carcinoma.

Authors:  Xin Li; Jia-Yun Lu; Li-Qun Zhao; Xiu-Qin Wang; Gui-Lin Liu; Zhong Liu; Chuan-Nong Zhou; Min Wu; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 2.  Ets transcription factors in intestinal morphogenesis, homeostasis and disease.

Authors:  Paul Jedlicka; Arthur Gutierrez-Hartmann
Journal:  Histol Histopathol       Date:  2008-11       Impact factor: 2.303

3.  Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.

Authors:  Claudia D Baldus; Sandya Liyanarachchi; Krzysztof Mrózek; Herbert Auer; Stephan M Tanner; Martin Guimond; Amy S Ruppert; Nehad Mohamed; Ramana V Davuluri; Michael A Caligiuri; Clara D Bloomfield; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

4.  Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.

Authors:  Nathalie Itzhar; Philippe Dessen; Saloua Toujani; Nathalie Auger; Claude Preudhomme; Catherine Richon; Vladimir Lazar; Véronique Saada; Anelyse Bennaceur; Jean Henri Bourhis; Stéphane de Botton; Alain Bernheim
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

5.  Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.

Authors:  Qinghua Li; Lu Yang; Kang Han; Liqiang Zhu; Yanting Zhang; Shanshan Ma; Kun Zhang; Bo Yang; Fangxia Guan
Journal:  Oncotarget       Date:  2016-09-20

6.  Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.

Authors:  D Chan; T J Wilson; D Xu; H E Cowdery; E Sanij; P J Hertzog; I Kola
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

7.  Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancers.

Authors:  Meghan L Verschoor; Chris P Verschoor; Gurmit Singh
Journal:  Cancer Metab       Date:  2013-07-25

8.  High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions.

Authors:  Lin Fu; Huaping Fu; Qingyun Wu; Yifan Pang; Keman Xu; Lei Zhou; Jianlin Qiao; Xiaoyan Ke; Kailin Xu; Jinlong Shi
Journal:  J Transl Med       Date:  2017-07-19       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.